CETP and coronary artery disorder: Since, CETP involve in the conversion of HDL to LDL/VLDL, we are tempted to conclude that rs1801706-A increases the risk of CAD by increasing rate of conversion of HDL to LDL/VLDL, through changing the half life of CETP mRNA.